Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/10/2003WO2003055454A1 New composition
07/10/2003WO2003055448A2 Antifungal compositions
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055446A2 Antifungal phenethylene
07/10/2003WO2003055445A2 Compositions and methods for enhancing corticosteriod delivery
07/10/2003WO2003055444A2 Resveratrol analogues
07/10/2003WO2003055442A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
07/10/2003WO2003055438A2 Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
07/10/2003WO2003055424A1 METHOD OF SYSTEMICALLY DELIVERING SSRIs
07/10/2003WO2003055335A1 Modified methionine rich food products and process for their manufacture
07/10/2003WO2003055324A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
07/10/2003WO2003043905A3 Pharmaceutical product with an adsorbent
07/10/2003WO2003041694A3 Use of compounds comprising iodine, strontium and ascorbic acid as well as either bismuth, zinc or potassium in the treatment of aids
07/10/2003WO2003041653A3 Cytotoxic agents
07/10/2003WO2003039437A3 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel
07/10/2003WO2003037298A3 Bowel cleansing agent
07/10/2003WO2003035107A8 Enzyme inhibitors for inactivating allergens
07/10/2003WO2003023015A3 Method for expression of small antiviral rna molecules within a cell
07/10/2003WO2003022274A3 2-aroylimidazole compounds for treating cancer
07/10/2003WO2003020289A9 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
07/10/2003WO2003017932A3 Compositions and methods for targeting cerebral circulation and treatment of headache
07/10/2003WO2003015872A3 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders
07/10/2003WO2003011227A3 Taste masking composition
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2003007880A3 Inhibition of behab cleavage and primary central nervous system (cns) tumors
07/10/2003WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2003002765A3 Methods for the diagnosis of cancer based on the obcam and ntm genes
07/10/2003WO2003002175A8 Enhanced systemic absorption of intradermally delivered substances
07/10/2003WO2003000861A3 Eukaryotic genes involved in adult lifespan regulation
07/10/2003WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
07/10/2003WO2002096368A3 Encapsulation of nanosuspensions in liposomes and microspheres
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002079778A3 In vivo delivery methods and compositions
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002042267A3 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
07/10/2003WO2002038166A3 Ginseng berry extracts and pharmaceutical compositions therefrom
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002013759A3 Method of treating the syndrome of type 2 diabetes in humans
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002009761A9 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
07/10/2003WO2002009675A9 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
07/10/2003WO2002005813A3 Method for preventing and/or decreasing amyloid production with polycyclic compounds
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003WO2001096523A3 Polynucleotides related to colon cancer
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003WO2001089364A9 Hcv variants
07/10/2003US20030130626 Apparatus with weeping tip and method of use
07/10/2003US20030130575 Method and apparatus for tissue treatment with laser and electromagnetic radiation
07/10/2003US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s)
07/10/2003US20030130518 They induce the biosynthesis of various cytokines and are useful in the treatment of viral and neoplastic diseases.
07/10/2003US20030130517 Useful as antiinflammatory drugs, particularly as remedies for rheumatoid arthritis
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130507 Reacting (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro -7H-pyrido(1,2,3-de) (1,4)benzoxazine-6-carboxylic acid with N-methyl piperazine at an elevated temperature to form levofloxacin; precipitation
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130359 Anesthetic comprising sevoflurane, enflurane, isoflurane, methoxyflurane, and/or desflurane stabilized with water, butylated hydroxytoluene, methylparaben, propylparaben, propofol, and thymol
07/10/2003US20030130357 Inhibiting ornithine decarboxylase (involved with production of putrescine) with N(1),N(11)-diethylnorspermine
07/10/2003US20030130356 Such as 5,46-dihydroxy-3,8,18,23,28,33,38,43,48-decaazapentacontane decahydrochloride; side effect reduction
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130354 Such as 3,5-dimethyl-1-adamantanecarboximidamide hydrochloride; glutamate receptors; methyl-D-aspartate receptors; neurodegenerative diseases; side effect reduction
07/10/2003US20030130353 Administering dual serotonin norepinephrine reuptake inhibitor
07/10/2003US20030130352 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis
07/10/2003US20030130351 Aersol forms of L-3,5,3',5'-tetraiodothyronine; dietetics
07/10/2003US20030130350 Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003US20030130345 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
07/10/2003US20030130344 Noscapine derivatives as adjuvant compositions and methods of use thereof
07/10/2003US20030130343 Such as 2-chloro-5-nitro-N-pyridin-4-yl-benzamide; dietetics; livestock feeds
07/10/2003US20030130341 Taxoids formed by conjugating paclitaxel/docetaxel to polyglutamic acid, polyaspartic acid, or polylysine; antitumor agents; treatment of rheumatoid arthritis and autoimmune diseases
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130338 Method of treatment
07/10/2003US20030130337 Indole derivatives as anti-inflammatory agents
07/10/2003US20030130335 Protein tyrosine phosphatases inhibitors
07/10/2003US20030130334 Methods and compositions for the treatment of psychiatric disorders
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130332 Method for prophylaxis and treatment of diabetic complications with 4[alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives
07/10/2003US20030130330 Materials and methods for the treatment of hypertension and angina
07/10/2003US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/10/2003US20030130323 Anorectic agents
07/10/2003US20030130322 Biaryl ether derivative as opiod antagonist
07/10/2003US20030130321 Method of resolving amlodipine racemate
07/10/2003US20030130319 Aminopyrrole compounds
07/10/2003US20030130317 Inhibition of glycolipid biosynthesis
07/10/2003US20030130316 Method for chemoprevention of prostate cancer
07/10/2003US20030130315 Administering a (R)-4-(1-hydroxy-4-(4-(hydroxydiphenyl methyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-benzeneacetic acid derivative
07/10/2003US20030130314 Administering 4-amido-piperidineo derivatives to patients already under the background influence of an opioid agonist
07/10/2003US20030130311 Using quinolinone drug
07/10/2003US20030130310 Quinolinone derivative pharmaceutical compositon and production method therefor
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130308 Drugs for spinal anesthesia
07/10/2003US20030130307 Heterocycles
07/10/2003US20030130306 Abntidiabetic agents, cardiovascular disorders, anticholesterol agents
07/10/2003US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
1 ... 5410 5411 5412 5413 5414 5415 5416 5417 5418 5419 5420 5421 5422 5423 5424 5425 5426 5427 5428 5429 5430 ... 7860